Ecthyma Gangrenosum
- 1 May 1979
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 114 (5) , 580-583
- https://doi.org/10.1001/archsurg.1979.01370290030005
Abstract
• Five burn patients with ecthyma gangrenosum were treated with gentamicin sulfate in an individualized aminoglycoside regimen. Dosages greater than the currently recommended 3 to 5 mg/kg/day were necessary and ranged from 15 to 30 mg/kg/day. These increased dosages cannot be used routinely but only as serum level data indicate the need. Four of the five patients survived their course of ecthyma gangrenosum. The single fatality received a much smaller dosage of gentamicin as compared with the other four patients. No ototoxic or nephrotoxic reactions were noted in any of the patients. (Arch Surg114:580-583, 1979)This publication has 7 references indexed in Scilit:
- Kinetic model for gentamicin dosing with the use of individual patient parametersClinical Pharmacology & Therapeutics, 1977
- GENTAMICIN DOSAGE IN CHILDREN WITH EXTENSIVE BURNSPublished by Wolters Kluwer Health ,1976
- Rapid Gentamicin Bioassay Using a Multiple-Antibiotic-Resistant Strain of Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1973
- Gentamicin in Newborn InfantsAmerican Journal of Diseases of Children, 1973
- Clinical Pharmacology of Gentamicin in Infants 2 to 24 Months of AgeArchives of Pediatrics & Adolescent Medicine, 1972
- PATHOGENESIS OF PSEUDOMONAS VASCULITIS AND SEPTIC LEGIONS1965
- THE CLINICAL SYMPTOMS, BACTERIOLOGIC FINDINGS AND POSTMORTEM APPEARANCES IN CASES OF INFECTION OF HUMAN BEINGS WITH THE BACILLUS PYOCYANEUS.Published by American Medical Association (AMA) ,1897